| Application no. and date | 11833515.7 (espacenet) (Federated) (European Patent Register), 20111014 | | Patent/reg. no. and date | DK/EP 2627334, 20150429 | | Publication date | 20130821 | | Priority no. and date | US 393522 P, 20101015, US 201161492054 P, 20110601 | | EP pub. no. and date |
EP 2627334 20130821 | | Effective date | | | Applicant/owner | Biocryst Pharmaceuticals, Inc., 4505 Emperor Blvd.
Durham, North Carolina 27703, US | | Applicant ref. no. | V1504-025-DK | | Inventor | BANTIA, Shanta, 689 Highland Lakes Cv
Birmingham AL 35242, US,
KOTIAN, Pravin, L., 1313 Atkins Trimm Blvd
Birmingham AL 35226-2016, US,
BABU, Yarlagadda, S., 4836 Southlake Pkwy
Birmingham AL 35244, US | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 31/215 (2006.01) , A61K 31/519 (2006.01) , A61K 45/06 (2006.01) , A61P 31/14 (2006.01) | | Title | Sammensætning til brug i behandling af virale infektioner | | Int. application no. | US2011056421 | | Int. publication no. | WO2012051570 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
